Industry litigation – Page 19
-
Business
AstraZeneca claims quashed in heartburn drug patent case
Nexium rival does not infringe on patent, court rules
-
Business
Chinese police seize £222m of fake drugs
1300 people are arrested in a nationwide crackdown on counterfeit medicines
-
Business
Court overturns approval to grow GM potato in Europe
Europe’s second highest court rules that European commission did not follow its own rules when giving Amflora the green light
-
BusinessNew wave of hepatitis C drugs hits US shore
J&J’s once-daily drug approved by FDA, but rivals are hot on its heels
-
Business
US turnaround on Avandia restrictions
Researchers accuse regulator of face-saving U-turn over diabetes medication safety
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits
-
BusinessMis-selling lands J&J with $2.2bn fine
Company found guilty of promoting three drugs for unapproved uses
-
BusinessPharma manufacturing woes dog industry
Regulators are stepping up inspections, and discovering ever more problems
-
NewsAnother drug suspension overturned in India
Safety concerns put sales of antidepressant Deanxit on ice until firms petitioned a high court
-
Business
Lundbeck appeals European antitrust fine
Danish pharmaceutical claims €93.8 million pay-for-delay penalty was the result of ‘serious legal and factual errors’
-
Business
Syngenta takes legal action over pesticide ban
Company claims that the European commission’s two-year moratorium on neonicotinoids to protect bees was wrong
-
Business
Couple charged in GSK corruption investigation
Two private investigators have been charged with breaching the privacy rights of Chinese citizens
-
BusinessObama mandate calls for safer chemical facilities
Agencies need to work together more effectively to improve safety
-
Business
Antiviral patents released by Roche
Firm will supply cheap drugs and allow generics in developing countries
-
Business
India revokes more pharma patents
Original molecule patent stands, but a new salt form is ‘not innovative’
-
BusinessLilly freezes pay as patent cliff looms
Drugmaker targets $400 million savings as two key patents near expiry
-
Business
GSK under investigation over corruption in China
Police claim executives engaged in bribery and tax-related crimes
-
BusinessTexas plant explosion prompts calls for stricter rules
The incident was caused by unregulated and improper storage of ammonium nitrate, investigators find